A multi-year agreement have been signed by Aquafil Group and the Genomatica Inc. to create sustainable caprolactam, an important ingredient for producing 100% sustainable bio based nylon.
On 23rd Jan, 2018 both the companies announced that the collaboration will be focusing on the development of Genomatica’s GENO CPL bioprocess on commercial scales and to produce caprolactam using plant-based renewable ingredients. According to the joint statement, caprolactam, used in a variety of nylon-based products including carpets and apparel, has a worldwide market of over five million tonnes per year.
Genomatica, which will licence the GENO CPL technology to Aquafil, claims that its technology can produce nylon “fully comparable” with fossil-based caprolactam. Additionally, the product will not require any machine or process adjustments by the nylon supply chain. Aquafil, a leading producer of nylon yarn, launched its ‘Econyl regeneration system’ in 2011 to produce nylon which is made from 100% recycled waste. The company currently supplies Econyl to sportswear, fashion, luxury and carpet brands as an alternative of their product.
“We aim to be a leader of sustainability for nylon, and we are excited by the opportunity to be the first to bring the benefits of this new technology to our customers, consumers and manufacturers look forward to opportunities to play an active role in the circular economy” Commenting on the partnership, Giulio Bonazzi, chairman and CEO of Aquafil added. Also adding to the comment, Christophe Schilling, CEO of Genomatica said, this was “another example of Genomatica applying the power of biology to rethink how widely-used chemicals can be made a better way.”